Camp prep can make summers better for kids
(Reuters Health) – Kids may have a much better – and safer – time at summer camp when parents plan ahead to make sure programs are a good fit for…
Average pregnant woman in U.S. may have poor nutrition
(Reuters Health) – Many pregnant women in the U.S. may not be getting enough of certain crucial nutrients, while others may be getting too much, a new study suggests. FILE…
Youth with chronic physical ailments more prone to mental illness
(Reuters Health) – Children and young adults with chronic conditions like asthma, diabetes, and ADHD may be more likely to develop mental illness than youth who don’t have physical health…
Heart problems may hasten cognitive decline
(Reuters Health) – Adults with clogged arteries carrying blood to the heart may be more prone to cognitive decline than their counterparts without such cardiac problems, a study suggests. This…
FDA approves drug for loss of sexual desire in women
(Reuters) – The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in premenopausal women, the latest attempt to come up with a…
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon…
GSK pharma head flags need for speed in high-pressure drug market
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain’s largest drugmaker…
Israel’s Zebra Medical gets FDA ok for brain bleeds product
TEL AVIV (Reuters) – Zebra Medical Vision, an Israel medical imaging analytics company, said on Monday it received its third clearance from the U.S. Food and Drug Administration for its…
Eleven U.S. cancer centers get to charge more for care
For several decades, certain cancer centers have been allowed by the U.S. government to charge more for the care they give. A new study finds the care given at these…
VBI’s shares plunge after hep B vaccine fails secondary goal in late-stage trial
(Reuters) – VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an…